Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: Do we really need it?

American Heart Journal

Volumn 159, Issue 1, 2010, Pages 98-102

  Calvi, Valeria ^a   Dugo, Daniela ^a   Capodanno, Davide ^a   Arancio, Rocco ^a   Di Grazia, Angelo ^a   Liotta, Claudio ^a   Puzzangara, Euglena ^a   Ragusa, Antonio ^a   Arestia, Alberto ^a   Tamburino, Corrado ^a  

^a Ferrarotto Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THERAPY EFFECT;

AGED; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSORY THRESHOLDS; STROKE VOLUME; TREATMENT OUTCOME; UNNECESSARY PROCEDURES; VENTRICULAR FIBRILLATION;

EID: 71849086249     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.10.031     Document Type: Article

References (22)

1. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
4. Mirowsky M., Reid P.R., Winkle R.A., et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 98 (1983) 585-588
5. Grubman E.M., Pavri B.B., Shipman T., et al. Cardiac death and stored ECG in patients with third generation implantable cardioverter-defibrillators. J Am Coll Cardiol 32 (1998) 1056-1062
6. Mitchell B., Pineda E.A., Titus J.L., et al. Sudden death in patients with implantable cardioverter-defibrillators-the importance of post-shock electromechanical dissociation. J Am Coll Cardiol 39 (2002) 1323-1328
7. Ideker R.E., Hillsley R.E., and Wharton J.M. Shock strength for the implantable defibrillator: can you have too much of a good thing. Pacing Clin Electrophysiol 15 (1992) 841-844
8. Gerstenfeld E.P. Defibrillation threshold testing: is one shock enough. Heart Rhythm 2 (2005) 123-124
9. Gold M.R., Olsovsky M.R., DeGroot P.J., et al. Optimization of transvenous coil position for active can defibrillation thresholds. J Cardiovasc Electrophysiol 11 (2000) 25-29
10. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J 29 (2008) 2388-2442
11. Zipes D.P., Jackman W.M., Heger J.J., et al. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 103 (1982) 789-794
12. Levy W.C., Lee K.L., Hellkamp A.S., et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation 120 (2009) 835-842
13. Lever N.A., Newall E.G., and Larsen P.D. Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation. Europace 9 (2007) 1054-1058
14. Strickberger S.A., Daoud E.G., Davidson T., et al. Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation 96 (1997) 1217-1223
15. Mainigi S.K., Cooper J.M., Russo A.M., et al. Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors. Heart Rhythm 3 (2006) 1010-1016
16. Blatt J.A., Poole J.E., Johnson G.W., et al. SCD-Heft Investigators. No benefit from defibrillation threshold testing in the SCD-Heft (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 52 (2008) 551-556
17. Curtis A.B. Defibrillation threshold testing in implantable cardioverter-defibrillators. Might less be more than enough. J Am Coll Cardiol 52 (2008) 557-558
18. Pires L.A., and Johnson K.M. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough. J Cardiovasc Electrophysiol 17 (2006) 140-145
19. Hall B., Jeevanantham V., Levine E., et al. Comparison of outcomes in patients undergoing defibrillation threshold testing at the time of implantable cardioverter-defibrillator implantation versus no defibrillation threshold testing. Cardiol J 14 (2007) 463-469
20. Gula L.J., Massel D., Krahn A.D., et al. Is defibrillation testing still necessary? A decision analysis and Markov model. J Cardiovasc Electrophysiol 19 (2008) 400-405
21. Birnie D., Tung S., Simpson D., et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 5 (2008) 387-390
22. Viskin S., and Rosso R. The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm 5 (2008) 391-393